Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Simultaneous quantification of SMN1 and SMN2 copy numbers by MALDI-TOF mass spectrometry for spinal muscular atrophy genetic testing. | Clin Chim Acta | 2022 | 35643151 | PubTator, text mining | PubMed |
| Phenotypic drug discovery: recent successes, lessons learned and new directions. | Nat Rev Drug Discov | 2022 | 35637317 | PubTator, text mining | PubMed |
| The Cure SMA Clinical Trial Experience Survey: A Study of Trial Participant Perspectives on Clinical Trial Management and Patient-Centric Management Practices. | Neurol Ther | 2022 | 35635603 | PubTator, text mining | PubMed |
| Splicing Modulation as a Promising Therapeutic Strategy for Lysosomal Storage Disorders: The Mucopolysaccharidoses Example. | Life (Basel) | 2022 | 35629276 | PubTator, text mining | PubMed |
| The Advent of Omics Sciences in Clinical Trials of Motor Neuron Diseases. | J Pers Med | 2022 | 35629180 | PubTator, text mining | PubMed |
| The Role of Transposable Elements of the Human Genome in Neuronal Function and Pathology. | Int J Mol Sci | 2022 | 35628657 | PubTator, text mining | PubMed |
| Adeno-Associated Viruses for Modeling Neurological Diseases in Animals: Achievements and Prospects. | Biomedicines | 2022 | 35625877 | PubTator, text mining | PubMed |
| Cas14a1-Mediated Nucleic Acid Diagnostics for Spinal Muscular Atrophy. | Biosensors (Basel) | 2022 | 35624569 | PubTator, text mining | PubMed |
| Antisense modulation of IL7R splicing to control sIL7R expression in human CD4+ T cells. | RNA | 2022 | 35613883 | PubTator, text mining | PubMed |
| Revealing diverse alternative splicing variants of the highly homologous SMN1 and SMN2 genes by targeted long-read sequencing. | Mol Genet Genomics | 2022 | 35612622 | PubTator, text mining | PubMed |
| Refinements and considerations for trio whole-genome sequence analysis when investigating Mendelian diseases presenting in early childhood. | HGG Adv | 2022 | 35586607 | PubTator, text mining | PubMed |
| Gene-based therapeutics for rare genetic neurodevelopmental psychiatric disorders. | Mol Ther | 2022 | 35585789 | PubTator, text mining | PubMed |
| Autophagy regulation by RNA alternative splicing and implications in human diseases. | Nat Commun | 2022 | 35585060 | PubTator, text mining | PubMed |
| Fatal thrombotic microangiopathy case following adeno-associated viral SMN gene therapy. | Blood Adv | 2022 | 35584395 | PubTator, text mining | PubMed |
| Response of plasma microRNAs to nusinersen treatment in patients with SMA. | Ann Clin Transl Neurol | 2022 | 35584175 | PubTator, text mining | PubMed |
| A mixed method study on the impact of living with spinal muscular atrophy in Malaysia from patients' and caregivers' perspectives. | Orphanet J Rare Dis | 2022 | 35578241 | PubTator, text mining | PubMed |
| A custom ddPCR method for the detection of copy number variations in the nebulin triplicate region. | PLoS One | 2022 | 35576196 | PubTator, text mining | PubMed |
| An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy. | Ann Clin Transl Neurol | 2022 | 35567422 | PubTator, text mining | PubMed |
| Scientific rationale for a higher dose of nusinersen. | Ann Clin Transl Neurol | 2022 | 35567345 | PubTator, text mining | PubMed |
| Advanced Gene-Targeting Therapies for Motor Neuron Diseases and Muscular Dystrophies. | Int J Mol Sci | 2022 | 35563214 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=48